Table of Contents: Oncotarget’s Volume 12, Issue #6

Read short summaries of the latest research literature published by Oncotarget.

Read a short summary of the latest research papers published by Oncotarget.
Read short summaries of the latest research papers published by Oncotarget.
Listen to an audio version of this post

Oncotarget’s Volume 12, Issue #6

New Publications

Cover (Research Paper): Genomic and neoantigen evolution from primary tumor to first metastases in head and neck squamous cell carcinoma

Origin: Missouri, New York, United States

Institutions: Washington University in St. Louis, Columbia University, St. Louis Children’s Hospital, Siteman Cancer Center

Quote: “We characterized genomic and neoantigen changes between 23 paired primary and recurrent HNSCC tumors. Twenty-three biopsies from patients originally diagnosed with locally advanced disease were identified from the Washington University tumor bank.”

Editorial Paper: Innovating and expanding weight loss strategies for breast cancer survivors

Origin: Maryland, United States

Institution: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Quote: “Compared to those with ideal body weight, women who have excess weight experience inferior outcomes once diagnosed with breast cancer, despite standard local and adjuvant therapy [6].”

Research Perspective: Pancreatic cancer driver mutations are targetable through distant alternative RNA splicing dependencies

Origin: Maryland, New Hampshire, Connecticut, New York, United States

Institutions: The Johns Hopkins University School of Medicine, Dartmouth Geisel School of Medicine and Norris Cotton Cancer Center, Yale University, Stony Brook University Renaissance School of Medicine

Quote: “Here, we review PDAC pathogenesis as it relates to fundamental ARS [Alternative RNA splicing] biology, with an extension to implications for PDAC patient clinical management.”

Research Paper: A high-content AlphaScreen™ identifies E6-specific small molecule inhibitors as potential therapeutics for HPV+ head and neck squamous cell carcinomas

Origin: California, Kansas, United States

Institutions: Loma Linda University, University of Kansas

Quote: “Herein we describe our search for small molecule inhibitors that disrupt binding of E6 to caspase 8 using AlphaScreen technology™ (Perkin Elmer, Waltham, MA). This technology is a proximity-based platform for identifying hit compounds that perturb a specific interaction between two beaded proteins. Using this approach, we interrogated a library of over 5000 small molecules for compounds that antagonize E6 binding to caspase 8.”

Research Paper: Characterization of the inflammatory microenvironment and hepatic macrophage subsets in experimental hepatocellular carcinoma models

Origin: Ghent, Belgium

Institution: Ghent University

Quote: “Here, we characterized the tumor microenvironment and the proportion and transcriptional profile of hepatic macrophages (Mφ) in two commonly used HCC mouse models.”

Research Paper: Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations

Origin: Maharashtra, Mumbai, India; Budapest, Hungary

Institutions: Tata Memorial Centre, Homi Bhabha National Institute

Quote: “We performed survival analyses of lung squamous cell carcinoma patients harboring therapeutically relevant alterations identified by whole exome sequencing and mass spectrometry-based validation across 430 lung squamous tumors.”

Click here to read Oncotarget’s Volume 12, Issue #6.

Oncotarget is a unique platform designed to house scientific studies in a journal format that is available for anyone to read—without a paywall making access more difficult. This means information that has the potential to benefit our societies from the inside out can be shared with friends, neighbors, colleagues, and other researchers, far and wide.

For media inquiries, please contact

Leave a Reply

Your email address will not be published. Required fields are marked *